RE: Moving Forwards29 Jan 2021 20:38
Porky, with all due respect, and I do love your enthusiasm...the company told you their guidance via the analyst community. You chose not listen. They have also told you quite a lot in that rns but you are again choosing not to listen. Moreover, how do you expect anyone to forecast covid? It changes day to day, week to week. I never expected we would be in full lock down again now, even at Christmas. Did you? But I can tell you that texting got it will be around a long time after 2021.
The company has said we need to connect the dots. We can do that. January will at least match December for number of tests. February and March same for October and November. Infact, as it’s stands I see now reason why ebitda for h1 21 won’t at least match that for h2 last year. That gives us 160m ebitda. They have said cash conversion rate is 80 percent. So that gives you an extra 130m of cash on top of the 100m cash they have plus a likely 50m tied up in working capital (they have said they have stock ready to go). That gives you an m&a war chest of nearly 300m in CASH this year.
They have also said they are a partner to the dhsc and In active dialogue. The government are still working out what they want their national testing infrastructure to look like post covid. But I would bet my life that ncyt will be part of it. All parties are working together and can’t rush the decisions given huge costs and how crucial it will be to future pandemic responses. It will happen thoughAnd the delay by the government is not exclusive to ncyt.
I sold some today so maybe I am a hypocrite but I am more confident than ever this business is going places and will be a diagnostics champion. We just need to stop demanding jam today now now now. Rome was not built in day. Listen to the company. Trust the company. And I am sure we will be very well reward as shareholders if we do that.